(Q33342985)

26 July 2017

1 reference

title

Gaucher disease: pediatric concerns (English)

1 reference

26 July 2017

1 reference

Deborah Elstein

1

1 reference

26 July 2017

Aya Abrahamov

2

1 reference

26 July 2017

Altoon Dweck

3

1 reference

26 July 2017

Irith Hadas-Halpern

4

1 reference

26 July 2017

Ari Zimran

5

1 reference

26 July 2017

publication date

1 January 2002

1 reference

26 July 2017

1 reference

26 July 2017

volume

4

1 reference

26 July 2017

issue

7

1 reference

26 July 2017

page(s)

417-426

1 reference

Increased basal glucose production in type 1 Gaucher's disease.

26 July 2017

cites work

1 reference

12 December 2020

Bone density in Type 1 Gaucher disease.

1 reference

12 December 2020

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.

1 reference

12 December 2020

Gaucher disease--Norrbottnian type. I. General clinical description

1 reference

12 December 2020

Enzyme therapy for Gaucher disease: the first 5 years

1 reference

12 December 2020

Commentary: low-dose high-frequency enzyme replacement therapy prevents fractures without complete suppression of painful bone crises in patients with severe juvenile onset type I Gaucher disease

1 reference

12 December 2020

Withdrawal of enzyme replacement therapy in Gaucher's disease

1 reference

12 December 2020

Gaucher disease mutations in non-Jewish patients

1 reference

12 December 2020

Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease

1 reference

12 December 2020

Skeletal involvement in Gaucher's disease

1 reference

12 December 2020

Ten years' experience of bone marrow transplantation for Gaucher disease.

1 reference

12 December 2020

Clinical and genetic studies of Japanese homozygotes for the Gaucher disease L444P mutation

1 reference

12 December 2020

Outcome of total hip arthroplasty in patients with Gaucher disease.

1 reference

12 December 2020

Plasma chitotriosidase activity in Gaucher disease patients who have been treated either by bone marrow transplantation or by enzyme replacement therapy with alglucerase

1 reference

12 December 2020

Effect of low-dose enzyme replacement therapy on bones in Gaucher disease patients with severe skeletal involvement

1 reference

12 December 2020

The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease.

1 reference

12 December 2020

Lung involvement and enzyme replacement therapy in Gaucher's disease

1 reference

12 December 2020

Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase

1 reference

12 December 2020

Asymptomatic Gaucher disease implications for large-scale screening

1 reference

12 December 2020

Outcome of partial splenectomy for type I Gaucher disease

1 reference

12 December 2020

Pulmonary function abnormalities in type I Gaucher disease.

1 reference

12 December 2020

Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector

1 reference

12 December 2020

A practical approach to diagnosis and management of Gaucher's disease

1 reference

12 December 2020

The molecular biology of Gaucher disease and the potential for gene therapy

1 reference

12 December 2020

1 reference

12 December 2020

Bone scans in the diagnosis of bone crisis in patients who have Gaucher disease

1 reference

12 December 2020

Children with type I Gaucher disease: growing into adulthood with and without enzyme therapy

1 reference

12 December 2020

Management of neuronopathic Gaucher disease: a European consensus.

1 reference

12 December 2020

Gaucher disease. Current issues in diagnosis and treatment. NIH Technology Assessment Panel on Gaucher Disease

1 reference

12 December 2020

Splenectomy in Gaucher disease: new management dilemmas

1 reference

12 December 2020

Echocardiographic assessment of pulmonary hypertension in Gaucher's disease

1 reference

12 December 2020

The clinical course of treated and untreated Gaucher disease. A study of 45 patients

1 reference

12 December 2020

Treatment of type 1 Gaucher's disease affecting bone with aminohydroxypropylidene bisphosphonate (pamidronate)

1 reference

12 December 2020

Ethical considerations for enzyme replacement therapy in neuronopathic Gaucher disease.

1 reference

12 December 2020

The nature and extent of jaw involvement in Gaucher disease: observations in a series of 28 patients

1 reference

12 December 2020

Gaucher's disease: molecular, genetic and enzymological aspects

1 reference

12 December 2020

The role of neurogenetics in Gaucher disease

1 reference

12 December 2020

Glucosylsphingosine accumulation in mice and patients with type 2 Gaucher disease begins early in gestation

1 reference

12 December 2020

10.2165/00128072-200204070-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1049290997

0 references

1 reference